- Home
- EVAX vs ADXN Comparison
EVAX vs ADXN Comparison
Compare EVAX & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVAX
- ADXN
- Stock Information
- Founded
- EVAX 2008
- ADXN 2002
- Country
- EVAX Denmark
- ADXN Switzerland
- Employees
- EVAX N/A
- ADXN N/A
- Industry
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- EVAX Health Care
- ADXN Health Care
- Exchange
- EVAX Nasdaq
- ADXN Nasdaq
- Market Cap
- EVAX 17.8M
- ADXN 8.0M
- IPO Year
- EVAX 2021
- ADXN N/A
- Fundamental
- Price
- EVAX $2.94
- ADXN $9.36
- Analyst Decision
- EVAX Strong Buy
- ADXN Strong Buy
- Analyst Count
- EVAX 2
- ADXN 1
- Target Price
- EVAX $10.00
- ADXN $30.00
- AVG Volume (30 Days)
- EVAX 71.6K
- ADXN 60.8K
- Earning Date
- EVAX 10-30-2025
- ADXN 09-01-2025
- Dividend Yield
- EVAX N/A
- ADXN N/A
- EPS Growth
- EVAX N/A
- ADXN N/A
- EPS
- EVAX N/A
- ADXN 0.10
- Revenue
- EVAX $3,176,000.00
- ADXN $278,508.00
- Revenue This Year
- EVAX N/A
- ADXN $86.57
- Revenue Next Year
- EVAX $425.50
- ADXN N/A
- P/E Ratio
- EVAX N/A
- ADXN $0.88
- Revenue Growth
- EVAX 1042.45
- ADXN N/A
- 52 Week Low
- EVAX $1.20
- ADXN $6.51
- 52 Week High
- EVAX $17.20
- ADXN $12.05
- Technical
- Relative Strength Index (RSI)
- EVAX 52.53
- ADXN 53.53
- Support Level
- EVAX $2.81
- ADXN N/A
- Resistance Level
- EVAX $3.04
- ADXN $12.05
- Average True Range (ATR)
- EVAX 0.20
- ADXN 0.28
- MACD
- EVAX -0.01
- ADXN -0.14
- Stochastic Oscillator
- EVAX 71.19
- ADXN 77.68
About EVAX Evaxion Biotech
Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.